Industrial Bioprocessing Market Outlook 2030: Market Size, CAGR, Trends And Forecast Analysis

Industrial Bioprocessing Market Size

The Business Research Company

The Business Research Company’s Industrial Bioprocessing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2026 /EINPresswire.com/ -- The industrial bioprocessing sector has witnessed substantial growth recently, reflecting its increasing significance in various manufacturing applications. Driven by advancements in biotechnology and rising demand for biological products, this market is set for continued expansion in the years ahead. Below is a detailed overview of the market size, key growth factors, major regional players, and emerging trends shaping its future.

Steady Expansion of the Industrial Bioprocessing Market Size
The industrial bioprocessing market has seen robust development over recent years. It is projected to grow from $18.95 billion in 2025 to $20.61 billion in 2026, marking a compound annual growth rate (CAGR) of 8.7%. This historical growth is largely driven by increasing demand in pharmaceutical manufacturing, the expansion of industrial enzyme production, wider adoption of fermentation-based technologies, greater investments in biotechnology research facilities, and the establishment of large-scale biomanufacturing infrastructure.

Download a free sample of the industrial bioprocessing market report:
https://thebusinessresearchcompany.com/sample_request?id=89476543&type=smp&name=Industrial%20Bioprocessing%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR

Forecasted Growth and Future Market Potential in Industrial Bioprocessing
Looking ahead, the industrial bioprocessing market is expected to experience strong growth, reaching $29.05 billion by 2030 with a CAGR of 9.0%. This surge is primarily attributed to rising demand for bio-based chemicals and fuels, growth in precision medicine and biologics manufacturing, an increasing focus on cost-effective biomanufacturing, adoption of cutting-edge cell culture technologies, and a push towards sustainable industrial production methods. Key trends influencing this growth include more widespread use of single-use bioprocessing systems to minimize contamination risks, heightened demand for efficient downstream purification technologies, expansion of large-scale fermentation capacities, preference for modular and adaptable bioreactor designs, and stronger emphasis on regulatory-compliant production processes that guarantee product quality and consistency.

Understanding Industrial Bioprocessing as a Manufacturing Technique
Industrial bioprocessing refers to a manufacturing approach that utilizes biological entities such as microorganisms, enzymes, or living cells to carry out controlled biological reactions on a commercial scale. This process combines biotechnology, process engineering, and real-time monitoring to enhance production efficiency, ensure consistent output, and promote sustainable operations.

View the full industrial bioprocessing market report:
https://www.thebusinessresearchcompany.com/report/industrial-bioprocessing-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR

Rising Demand for Biologics and Biopharmaceuticals Propelling Market Growth
A major factor driving the industrial bioprocessing market is the growing demand for biologics and biopharmaceuticals. These complex medicines, produced using living organisms or cells, offer targeted treatments for various medical conditions through biological mechanisms. The increasing prevalence of chronic diseases is accelerating the adoption of these therapies, as they often provide better clinical outcomes compared to traditional drugs. Industrial bioprocessing plays a crucial role by facilitating the large-scale cultivation of cells and microorganisms required for the production of these biological drugs with high purity and consistency via controlled fermentation and downstream processing methods. For instance, in January 2023, Cardinal Health Inc. reported that the US had 33 FDA-approved biosimilars as of January 2022, with 21 commercially available. By 2023, the number of FDA-approved biosimilars increased to 40, with 25 on the market, highlighting the expanding demand that supports growth in industrial bioprocessing.

How Regional Markets Shape the Industrial Bioprocessing Landscape
In 2025, North America held the largest share of the industrial bioprocessing market, establishing itself as the dominant region. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period. The industrial bioprocessing market report covers multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive global perspective on market dynamics.

What’s new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
email us here
Visit us on social media:
LinkedIn
Facebook
X